NEW DELHI: Tackling tobacco dependence through sustained cessation support, alongside controlling high blood pressure, is crucial to reducing India's stroke burden, experts said on the eve of World Stroke Day, calling for a stronger public-health response that goes beyond awareness…
“Huntsman Cancer Institute gives you hope with the research that they do and with all the people who are involved in their staff. They give you hope when you’re really hopeless." Amanda KellumMother of Porter Kellum, cancer patient at Huntsman…
One in four patients with oropharyngeal cancer in South Korea was found to be infected with an HPV genotype other than HPV 16. In particular, patients infected with HPV 33 had a higher cervical lymph... HPV Genotypes Affect Oropharyngeal Cancer Survival, With…
A 2024 analysis of Global Burden of Disease data estimated that tobacco use contributed to 12 per cent of stroke deaths in India, while high systolic blood pressure accounted for 56 per cent, highlighting the need to address multiple risk factors through prevention…
On World Stroke Day, health experts emphasize that tobacco control must go beyond awareness to include effective cessation support and nicotine dependency treatment to combat the rising burden of stroke and cardiovascular disease in India. A 2024 analysis of Global Burden…
Genmab A/S (GMAB) reported positive results form a Phase 3 trial evaluating Petosemtamab plus Keytruda (pembrolizumab) as a first-line treatment for patients with PD-L1 positive recurrent or metastatic head and neck cancer. The combination significantly improved overall survival and tumor…
by Lee Jong-cheol, professor of otolaryngology at Gangneung Asan Hospital This article has been translated AI. Registration Number: Seoul, Ah01174 Registration Date: 2010.03.19 Date of issue: October 14, 2005 Editor: Im Ho-jun Title: Health Chosun Company Name: Health Chosun Co.Ltd Address: 30, Sejongdaero 21-gil,…
Sometimes, moving just a few inches can go a long way. Osaka Metropolitan University researchers have developed a promising technique for head and neck reconstruction that shifts the placement of transferred tissue with blood vessels attached, offering a safer, faster…
COPENHAGEN, Denmark; October 28, 2026 Based on these positive topline results, Genmab plans to engage global regulatory authorities and will submit the full results from LiGeR-HN1 for presentation at a future medical meeting. On Wednesday, October 28 at 5:00 p.m. CET/12:00 p.m. EDT, Genmab will host…
Genmab (GMAB) reported updated Phase 2 results showing that Potesemtamab in combination with Pembrolizumab delivered encouraging survival and response rates in patients with first-line recurrent or metastatic PD-L1-positive head and neck squamous cell carcinoma. Head and neck squamous cell carcinoma…
Mouth, throat and other head and neck cancers, including those linked to HPV, and thyroid cancer.
An article joins this feed when it matches these terms. Each one is also a search of its own.